CONTACT US: Contact info
|
Citation |
Krupp LB. Therapy 2008; 5(5): 641-651. |
|
Copyright |
(Copyright © 2008) |
|
DOI |
|
PMID |
unavailable |
|
Abstract |
An increasing number of children and adolescent with multiple sclerosis are being identified and treated with disease-modifying therapies. As more rapid diagnosis is made possible due to the heightened awareness of pediatric multiple sclerosis among the pediatric and neurological communities, and the availability of MRI, the number of pediatric multiple sclerosis patients requiring treatment will grow over time. This review draws on information from adult and pediatric neurology sources and summarizes current available data on the management of pediatric multiple sclerosis. © 2008 Future Medicine Ltd. Language: en |
|
Keywords |
human; pediatrics; prognosis; Treatment; family; exercise; insomnia; depression; social support; anxiety; suicide attempt; major depression; clinical trial; disease severity; Diagnosis; mood disorder; pain; awareness; review; fatigue; antidepressant agent; differential diagnosis; acute disease; cognitive defect; fluoxetine; serotonin uptake inhibitor; nuclear magnetic resonance imaging; steroid; drug safety; placebo; clinical protocol; carbamazepine; drug efficacy; drug tolerability; nausea; leukopenia; drug withdrawal; drug megadose; muscle hypertonia; hypertension; relapse; gabapentin; side effect; cholinergic receptor blocking agent; infection; asthenia; arthralgia; flu like syndrome; myalgia; plasmapheresis; diagnostic procedure; methylprednisolone; thorax pain; multiple sclerosis; baclofen; hyperglycemia; drug dose regimen; motor dysfunction; tizanidine; arthritis; drug bioavailability; blood cell count; beta1a interferon; glatiramer; drug induced headache; drug dose titration; injection site reaction; drug substitution; enteropathy; oxybutynin; interferon beta serine; prednisone; donepezil; Glatiramer acetate; natalizumab; spasticity; liver function test; vasodilatation; muscle spasm; morning dosage; urinary dysfunction; abnormal laboratory result; immunoglobulin; drug dose escalation; 4 aminopyridine; Interferon-β; Pediatric MS; solifenacin; tolterodine |